59
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Do treatment patterns differ in those with early-onset colorectal cancer?

, , , , &
Pages 313-323 | Received 07 Dec 2023, Accepted 25 Mar 2024, Published online: 15 Apr 2024

References

  • Siegel RL, Soerjomataram I, Hayes RB, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. [Internet]. 2019;68(12):2179–2185. doi: 10.1136/gutjnl-2019-319511
  • Gandhi J, Davidson C, Hall C, et al. Population-based study demonstrating an increase in colorectal cancer in young patients. Br J Surg. 2017 Jul 1;104(8):1063–1068. doi: 10.1002/bjs.10518
  • Chittleborough TJ, Gutlic I, Pearson JF, et al. Increasing incidence of young-onset colorectal carcinoma a 3-country population analysis. Dis Colon Rectum. 2020 Jul 1;63(7):903–910. doi: 10.1097/DCR.0000000000001631
  • O’Connell JB, Maggard MA, Liu JH, et al. Do young colon cancer patients have worse outcomes? World J Surg. 2004;28(6):558–562. doi: 10.1007/s00268-004-7306-7
  • Abdelsattar ZM, Wong SL, Regenbogen SE, et al. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. [Internet]. 2016 Mar 15;122(6): 929–934. doi: 10.1002/cncr.29716
  • Jin T, Li X, Ji J, et al. Comparison of the short-and long-term prognosis of early-onset colorectal cancer compared with later-onset colorectal cancer: A systematic review and meta-analysis. Health Sci Rep. 2023 Jun 12;6(6):e1307. doi: 10.1002/hsr2.1307
  • NCCN guidelines 2022. Treatment by Cancer Type [Internet]. [cited 2022 Sep 13]; Available from: https://www.nccn.org/guidelines/category_1.
  • Cavestro GM, Mannucci A, Balaguer F, et al. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) international management guidelines. Clin Gastroenterol Hepatol. 2023 Mar;21(3):581–603.e33.
  • Burnett-Hartman AN, David Powers J, Chubak J, et al. Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network. Cancer Causes & Control. [Internet]. 2019;30(7):747–755. doi: 10.1007/s10552-019-01181-3
  • Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol. 2007;14(10):2759–2765. doi: 10.1245/s10434-007-9465-x
  • Jackson C, Sharples K, Firth M, et al. The PIPER project. Report prepared for Health Research Council and Ministry Health of New Zealand. 2015.
  • Kneuertz PJ, Chang GJ, Hu CY, et al. Overtreatment of young adults with colon cancer more intense treatments with unmatched survival gains. JAMA Surg. 2015;150(5):402–409. Internet. doi: 10.1001/jamasurg.2014.3572
  • O’sullivan DE, Cheung WY, Boyne DJ, et al. Treatment patterns and survival outcomes of early-onset colorectal cancer patients in Alberta, Canada: a population-based study. Cancer Treat Res Commun Internet. 2022;32:100585. doi: 10.1016/j.ctarc.2022.100585
  • Birkett RT, Chamely E, Concors SJ, et al. Overuse and limited benefit of chemotherapy for stage II colon cancer in young Patients. Clin Colorectal Cancer. 2019;18(4):292–300. doi: 10.1016/j.clcc.2019.04.002 Internet.
  • Gao XH, Li J, Liu LJ, et al. Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: A retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center. Int J Surg. 2022 Aug 1;104:106780. doi: 10.1016/j.ijsu.2022.106780
  • Manjelievskaia J, Brown D, McGlynn KA, et al. Chemotherapy use and survival among young and middle-aged patients with colon cancer. JAMA Surg. 2017 May 1;152(5): 452. Internet. doi: 10.1001/jamasurg.2016.5050
  • Te Aho o Te Kahu. Update on Polyp Surveillance Guidelines 2020 | Ministry of Health NZ. Internet. 2020 [cited 2023 Feb 21]; Available from]. https://www.health.govt.nz/publication/update-polyp-surveillance-guidelines-2020
  • R studio team. RStudio: integrated Development for R. Boston MA: RStudio, PBC; 2020.
  • Cercek A, Chatila WK, Yaeger R, et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J Natl Cancer Inst. 2021 Nov 29;113(12):1683–1692. Internet. doi: 10.1093/jnci/djab124
  • Kolarich A, Thomas J, Jr G, et al. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline–directed treatment for stage II and III disease. Cancer. 2018;124(17):3510–3519. doi: 10.1002/cncr.31527
  • Zhang Y, Yan L, Wu Y, et al. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer. BMC Cancer. 2020 Sep 5;20(1): 1–10. Internet. doi: 10.1186/s12885-020-07359-2
  • Calderillo G, Herrera M, Lopez H, et al. P-130 Impact of age on efficacy of neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC). Ann Oncol. 2016 Jun;27:ii38. doi: 10.1093/annonc/mdw199.124
  • Gray R, Barnwell J, McConkey C, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007 Dec 15;370(9604): 2020–2029. Internet. doi: 10.1016/S0140-6736(07)61866-2
  • Booth CM, Nanji S, Wei X, et al. Adjuvant chemotherapy for stage ii colon cancer: practice patterns and effectiveness in the general population. Clin Oncol. 2017 Jan 1;29(1):e29–38. doi: 10.1016/j.clon.2016.09.001
  • Hirsch BR, Yousuf Zafar S. Capecitabine in the management of colorectal cancer. Cancer Manag Res. [Internet]. 2011;3:79–89. doi: 10.2147/CMAR.S11250
  • Tofthagen C. Surviving chemotherapy for colon cancer and living with the consequences. J Palliative Med. 2010 Nov 19;13(11):1389–1391. Internet doi: 10.1089/jpm.2010.0124
  • Hsu HT, Wu LM, Lin PC, et al. Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy: A cross-sectional study. Medicine. 2020 Feb;99(6):e19029.
  • Tofthagen C, Donovan KA, Morgan MA, et al. Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer. 2013 Dec;21(12):3307. Internet. doi: 10.1007/s00520-013-1905-5
  • Liang YH, Shao YY, Chen HM, et al. Young patients with colorectal cancer have increased risk of second primary cancers. Jpn J Clin Oncol. 2015 Nov 1;45(11): 1029–1035. Internet. doi: 10.1093/jjco/hyv137
  • Yellen SB, Cella DF. Someone to live for: social well-being, parenthood status, and decision-making in oncology. J Clin Oncol. 1995 Sep 21;13(5):1255–1264. doi: 10.1200/JCO.1995.13.5.1255
  • Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol. 2006 Jul 20;24(21):3490–3496. doi: 10.1200/JCO.2005.03.6236
  • Chouhan H, Ferrandon S, Devecchio J, et al. A changing spectrum of colorectal cancer biology with age: implications for the young patient. Dis Colon Rectum. 2019 Jan 1;62(1): 21–26. Internet. doi: 10.1097/DCR.0000000000001188
  • Ministry of Health. Ministry of Health. Molecular Testing of Colorectal Cancers in New Zealand: Minimum standards for molecular testing of newly diagnosed colorectal cancers. Ministry of Health NZ. 2018 [cited 2024 Feb 21]
  • Ministry of Health NZ. New Zealand Health Survey. [Internet]. [cited 2024 Feb 21]; Available from: https://www.health.govt.nz/nz-health-statistics/surveys/new-zealand-health-survey
  • Sluyter JD, Schaaf D, Metcalf PA, et al. Dietary intakes of Pacific, Māori, Asian and European adolescents: the Auckland high school heart survey. Aust N Z J Public Health. 2010 Feb 1;34(1):32–37. doi: 10.1111/j.1753-6405.2010.00470.x
  • Māori population estimates: 30 Jun 2023 | Stats NZ [Internet]. [cited 2024 Feb 21]. Available from: https://www.stats.govt.nz/information-releases/maori-population-estimates-at-30-june-2023
  • Lao C, Kuper-Hommel M, Laking G, et al. Evidence of inequitable use of chemotherapy in New Zealand colorectal cancer patients. N Z Med J. 2020;133(1520):15–26.
  • Hill S, Sarfati D, Robson B, et al. Indigenous inequalities in cancer: what role for health care? ANZ J Surg. 2013;83(1–2):36–41. doi: 10.1111/ans.12041
  • Hill S, Sarfati D, Blakely T, et al. Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Community Health. 2010 Feb;64(2):117–123.
  • Te Aho o Te Kahu, Cancer control agency. He Pūrongo Mate Pukupuku o Aotearoa 2020, the State of Cancer in New Zealand 2020. (revised mar 2021). Available from: https://teaho.govt.nz/reports/cancer-state
  • Fontana E, Meyers J, Sobrero A, et al. Early-onset colorectal adenocarcinoma in the IDEA database: Treatment adherence, toxicities, and outcomes with 3 and 6 months of adjuvant fluoropyrimidine and oxaliplatin. J Clin Oncol. 2021;39(36):4009–4019. doi: 10.1200/JCO.21.02008 Internet.
  • Zhang Y, Wang Y, Liu X, et al. Worse prognosis in young patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A comparative study. Medicine. 2020 Aug 8;99(35): e21304. Internet. doi: 10.1097/MD.0000000000021304
  • Waddell O, Mclauchlan J, McCombie A, et al. Quality of life in early-onset colorectal cancer patients: systematic review. BJS Open. 2023 May 5;7(3):zrad030. doi: 10.1093/bjsopen/zrad030

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.